H

Herantis Pharma Oyj
OMXH:HRTIS

Watchlist Manager
Herantis Pharma Oyj
OMXH:HRTIS
Watchlist
Price: 1.555 EUR -5.76% Market Closed
Market Cap: 31.3m EUR
Have any thoughts about
Herantis Pharma Oyj?
Write Note

Wall Street
Price Targets

HRTIS Price Targets Summary
Herantis Pharma Oyj

Wall Street analysts forecast HRTIS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRTIS is 1.479 EUR with a low forecast of 0.707 EUR and a high forecast of 2.31 EUR.

Lowest
Price Target
0.707 EUR
55% Downside
Average
Price Target
1.479 EUR
5% Downside
Highest
Price Target
2.31 EUR
49% Upside
Herantis Pharma Oyj Competitors:
Price Targets
CORT
Corcept Therapeutics Inc
46% Upside
326030
SK Biopharmaceuticals Co Ltd
24% Upside
HIKAL
Hikal Ltd
21% Upside
4551
Torii Pharmaceutical Co Ltd
3% Upside
4547
Kissei Pharmaceutical Co Ltd
2% Downside
VIRP
Virbac SA
33% Upside
LABB
Genomma Lab Internacional SAB de CV
3% Upside
ORCHPHARMA
Orchid Pharma Ltd
8% Downside

Revenue
Forecast

Revenue Estimate
Herantis Pharma Oyj

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Herantis Pharma Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
31%
Average Beat

Net Income
Forecast

Net Income Estimate
Herantis Pharma Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HRTIS's stock price target?
Price Target
1.479 EUR

According to Wall Street analysts, the average 1-year price target for HRTIS is 1.479 EUR with a low forecast of 0.707 EUR and a high forecast of 2.31 EUR.

Back to Top